PB2296: ROBUST BRUTON’S TYROSINE KINASE (BTK) DEGRADATION WITH NX-5948, AN ORAL BTK DEGRADER, IN A FIRST-IN-HUMAN PHASE 1A TRIAL IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY B CELL MALIGNANCIES

Detalles Bibliográficos
Autores principales: Linton, Kim, Forconi, Francesco, Lewis, David, Riches, John, El-Sharkawi, Dima, Gleeson, Mary, Injac, Sarah G, Nandakumar, Srinand, Tan, May, Cherala, Ganesh, Collins, Graham P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428929/
http://dx.doi.org/10.1097/01.HS9.0000975912.59317.8d
Descripción
Sumario:

Ejemplares similares